SciELO - Scientific Electronic Library Online

 
vol.128 issue8Salivary gland scintigraphy and lip biopsy in patients with Sjögren syndrome and normal controlsThyroid hemiagenesis associated to Basedow-Graves disease.: Report of one case author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

MANTEROLA D, Carlos et al. Clinical features of 29 patients with hepatocellular carcinoma. Rev. méd. Chile [online]. 2000, vol.128, n.8, pp.887-895. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872000000800008.

Background: Hepatocellular carcinoma is the most frequent primary tumor of the liver. It is associated to chronic liver diseases and has a high prevalence in some regions of Africa and Asia. Aim: To describe the clinical characteristics of patients with hepatocellular carcinoma, admitted to two hospitals of the IX region of southern Chile. Material and methods: Prospective study of 29 consecutive patients admitted to two hospitals in Temuco, Chile. Clinical features, laboratory values and viral markers were analyzed. Results: Eighteen patients were male and ages ranged from 29 to 75 years old. The most frequent presenting symptom was abdominal pain in 21 patients. Seven subjects had a history of alcoholism. Serum bilirubin values ranged from 0.1 to 15.8 mg/dl, alkaline phosphatases ranged from 171 to 3476 U/l, ASAT from 24 to 5400 U/l and alpha feto protein from 1.4 to 350 ng/ml. Two patients had a positive hepatitis B surface antigen and all had negative hepatitis C virus antibodies. Mean tumoral diameter was 9.6 cm and the most common presentation was nodular. Mean survival after the diagnosis was 6.3 months. Conclusions: These patients with hepatocellular carcinoma have a low frequency of positive viral markers and tumors of large sizes on presentation. (Rev Méd Chile 2000; 128: 887-95).

Keywords : Alcoholism; Carcinoma, hepatocellular; Hepatitis B antigens; Hepatitis C antibodies.

        · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License